Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
VELQORA (VLQ) Explores the Development of an AI-Powered Service Ecosystem
Author Catherine Martell Tackles Bullying with Heart and Humor in Third Installment of the Beloved “Runty Ralph” Children’s Book Series
Rural Poverty to Purpose: Charlene Young’s Inspiring Journey in Pathways of a Life: Chances and Choices: Volume 1
LifeSafety.ai RebraLifeSafety.ai nds as SiteChief to Reflect Its Growth Into a Complete Site Safety and Compliance Platform
DreamyGems Launches Everyday Fine Jewelry in 100% Recycled Metal
InvidiaTrade: AI won’t replace the trader but it could change how traders make decisions
Kari Hanson’s Debut Picture Book Life on a Vine Invites Children to See the Natural World Through a Pumpkin’s Eyes
Based on a True Family Story, Agnieszka Singh Releases Love Who You Are, a Children’s Book About Self-Acceptance
SUNART Unveils New Light‑Outdoor Apparel Collection: Bringing Professional‑Grade Outdoor Technology to Reimagine Urban Design Language
Meydan Free Zone Wins Two Awards at the Marquee Awards 2026 for Performance Marketing and SEO
Here’s what happened in crypto today
France is world’s most dangerous place for Bitcoiners: 90 attacks in 7 months
Nobel Peace Prize awarded to human rights pioneer Navi Pillay
Two Renoir paintings stolen from French museum are recovered
Cocktail of the week: All Roads’ daiquiri – recipe | The good mixer
Beauty’s Next Growth Engine is Live
Computer scientist David Silver: ‘Where are we going without AI?’
The Best Mac Desktop to Buy (2026): Mac Mini, Mac Studio, or iMac?
Dunking on Dating App Profiles Is Content Gold. People Are Getting Sick of It
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute